NOVOSENSE (02676) announced its allotment results, with a global offering of 19.0684 million shares. The Hong Kong public offering accounted for 10% of the total, while the international offering made up the remaining 90%. The issue price was set at HK$116 per share, raising approximately HK$2.0964 billion in net proceeds. Each board lot consists of 100 shares, and the H-shares are expected to commence trading on the Hong Kong Stock Exchange at 9:00 a.m. on Monday, December 8, 2025. The Hong Kong public offering was oversubscribed by 25.33 times, and the international offering was oversubscribed by 2.65 times.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments